Terminology Service for NFDI4Health
JSON

CMF Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C9874

A chemotherapy regimen consisting of cyclophosphamide, methotrexate and fluorouracil, used as a neoadjuvant or adjuvant treatment for breast cancer; also used for the treatment of recurrent and metastatic breast cancer. [ ]

Term info

Label

CMF Regimen

Synonyms
  • CMF
  • CMF Regimen
  • CMF regimen
  • CTX/5-FU/MTX
  • Cyclophosphamide/Fluorouracil/Methotrexate
  • Cytoxan-Methotrexate-Fluorouracil Regimen
  • Oral Cyclophosphamide/Methotrexate/Fluorouracil
Subsets

NCIT_C160952, NCIT_C160950

ALT DEFINITION

An abbreviation for a chemotherapy combination used alone or with other therapies to treat breast cancer. It is also being studied in the treatment of other types of cancer. It includes the drugs cyclophosphamide, methotrexate, and fluorouracil.

Accepted Therapeutic Use For

Neoadjuvant, Adjuvant, Recurrent, or Metastatic Breast Cancer

DesignNote

Source: NCCN Guidelines 2017

Legacy Concept Name

Cyclophosphamide_Fluorouracil_Methotrexate

Preferred Name

CMF Regimen

Semantic Type

Therapeutic or Preventive Procedure

UMLS CUI

C0950521

code

C9874